Insider Transactions in Q1 2022 at Theravance Biopharma, Inc. (TBPH)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2022
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Open market or private sale
|
Direct |
2,356
-0.7%
|
$23,560
$10.16 P/Share
|
|
Feb 25
2022
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
170,000
+10.5%
|
-
|
|
Feb 18
2022
|
Ann Brady PRESIDENT, TBIL |
SELL
Payment of exercise price or tax liability
|
Direct |
8,369
-7.05%
|
$75,321
$9.61 P/Share
|
|
Feb 18
2022
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Payment of exercise price or tax liability
|
Direct |
11,824
-3.4%
|
$106,416
$9.61 P/Share
|
|
Feb 18
2022
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Payment of exercise price or tax liability
|
Direct |
20,377
-4.98%
|
$183,393
$9.61 P/Share
|
|
Feb 18
2022
|
Andrew A. Hindman SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
25,973
-5.12%
|
$233,757
$9.61 P/Share
|
|
Feb 18
2022
|
Kenneth R Pitzer SVP, PROD STRAT & COMM PLNG |
SELL
Payment of exercise price or tax liability
|
Direct |
27,299
-6.7%
|
$245,691
$9.61 P/Share
|
|
Feb 18
2022
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
22,710
-1.74%
|
$204,390
$9.61 P/Share
|
|
Feb 07
2022
|
Kenneth R Pitzer SVP, PROD STRAT & COMM PLNG |
BUY
Grant, award, or other acquisition
|
Direct |
52,000
+11.32%
|
-
|